Israel Englander Zoetis Inc. Call Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $12.3 Million - $14 Million	-71,400 Reduced 76.28%	22,200 $4.34 Million
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $8.63 Million - $10.6 Million	-59,300 Reduced 38.78%	93,600 $16.2 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $7.19 Million - $8.68 Million	43,400 Added 39.63%	152,900 $25.9 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $15.1 Million - $20 Million	99,900 Added 1040.63%	109,500 $21.6 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $1.67 Million - $1.94 Million	-10,400 Reduced 52.0%	9,600 $1.65 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $1.69 Million - $2.03 Million	11,600 Added 138.1%	20,000 $3.33 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $577,015 - $692,868	4,400 Added 110.0%	8,400 $1.23 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $563,502 - $693,690	-3,800 Reduced 48.72%	4,000 $593,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.